CytoDyn (OTCMKTS:CYDY) Stock Sees High Volatility: What’s The Buzz?
Late-stage biotechnology company developing innovative treatments for multiple therapeutic indications, CytoDyn (OTCMKTS:CYDY), on August 2, 2021 announced that director nominations done by activist group led by Bruce Patterson and Paul Rosenbaum were invalid. The Rosenbaum/Patterson Group made efforts for nominating five director candidates for taking control of the firm’s Board of Directors. The company’s bylaws include standard “advance notice bylaw” for shareholder protection, requiring some disclosures by nominating shareholders for…